Most Recent
Acciona is mulling a bid to summarily dismiss a "hopelessly flawed" patent suit by its construction partner on the troubled East Rockingham waste-to-energy plant project, saying it is doomed in light of a High Court decision holding a patentee’s rights are exhausted at the time of sale.
Suspecting infringement of patents for its Parkinson's drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.
The High Court has been asked to clarify the extent to which computer-implemented ideas are eligible for patent protection, with IP Australia appealing a win for gaming giant Aristocrat.
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera's bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.
Samsung Bioepis has successfully opposed Janssen's bid to patent a monoclonal antibody to treat ulcerative colitis, but an IP Australia delegate has given the J&J-owned company a chance to fix its application.
Sports merchandise company Fanatics is going another round in its trade mark fight with AFL apparel maker FanFirm, urging the High Court to give guidance on the defence of honest concurrent use.
It faced defeat at the Full Federal Court and encountered a deadlocked High Court, still Aristocrat persisted in its seven-year fight to get patent protection for the popular Lightning Link poker machine. The long game paid off.
Genomic sequencing company Oxford Nanopore Technologies has sued MGI Australia alleging infringement of four patents covering nanopore technology.
A patent holding company is challenging the dismissal of its infringement case over Apple's Touch ID and Face ID technology.
The Full Court has upheld the cancellation of a US sports merchandise company's 'Fanatics' trade mark, agreeing it knew about Australian AFL merchandise maker FanFirm’s trade marks when it chose its name.